Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: J Perinatol. 2023 Jul 25;43(9):1158–1165. doi: 10.1038/s41372-023-01737-x

Table 2:

Outcomes by Early Antibiotic Exposure Status

Outcome Overall cohort
 (n=88,574)
Antibiotic exposure days 0–2
 (n= 75,353)
No antibiotic exposure days 0–2
 (n= 13,221)
p-value
Outcomes during days 3–7
 LOI 1,437 (1.6%) 1,154 (1.5%) 283 (2.1%) <0.001
 NEC/SIP 1,398 (1.6%) 1,290 (1.7%) 108 (0.8%) <0.001
 Death 1,726 (1.9%) 1,566 (2.1%) 160 (1.2%) <0.001
 Composite: LOI + death 3,055 (3.4%) 2,633 (3.5%) 422 (3.2%) 0.08
Age at death for those dying on days 3–7, (median [IQR]) 5 [3 – 6] 5 [3 – 6] 4 [3 – 6] 0.12
Outcomes after day 7
 LOI after day 7 9,834 (11%) 8,916 (12%) 918 (7%) <0.001
 NEC after day 7 5,680 (6%) 5,099 (7%) 581 (4%) <0.001
 Death after day 7, prior to NICU discharge 4,840 (6%) 4,518 (7%) 322 (3%) <0.001
 Age at death (days) for those dying after 7 days, (median [IQR]) 21 [13 – 39] 21 [13 – 39] 21 [12 – 35] 0.23